3Arii S,Yamaoka Y,Futagawa S,et al.Results of surgical and non-surgical treatment for small-sized hepatocellular carcinomas:a retrospective and nationwide survey in Japan[J].Hepatology,2000,32(6):1224-1229.
4Farges O,Regimbeau JM,Belghiti J.Aggressive management of recurrence following surgical resection of hepatoceUular carcinoma[J].Hepatogastroenterology,1998,45(s):1275-1280.
5YangC,ZeisbergM,LivelyJC,et al.Integrinalphal betal andalpha2 betal are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment[J].Cancer Res,2003,63(23):8312-8317.
6Chao Y,Li CP,Chau GY,et al.Prognostic significance of vascular endothelial growth factor,basic fibroblast growth factor,and angiogenin in patients with respectable hepatocellular carcinoma after surgery[J].Ann Surg Oncol,2003,10(4):355-362.
7Rooprai HK,Rucklidge GJ,Panou C,et al.The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells[J].Br J Cancer,2000,82(1):52-55.
8Giannelli G,Bergamini C,Fransvea Eo et al.Human hepatoeellular carcinoma (HCC) cells require both alpha3betal integrin and matrix metalloproteinases activity for migration and invasion[J].Lab Invest,2001,81 (4):613-627.
9Arii S,Mise M,Harada T,et al.Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential[J].Hepatology,1996,24(2):316-322.
10Yoshizaki T,Sato H,Furukawa M,et al. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1[J]. Proc Natl Sci USA,1998,95 (7) :3621-3626.
